Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Oct 24, 2014 brown michael s Director Option Execute 5,000 57.11
Oct 24, 2014 goldberg murray a Officer Automatic Sell 26,788 395.96 - 404.18
Oct 23, 2014 goldberg murray a Officer Automatic Sell 33,212 391.93
Oct 23, 2014 goldberg murray a Officer Option Execute 60,000 30.63
Oct 16, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 122,127 328.47 - 339.93
Oct 15, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 158,368 323.90 - 334.81
Oct 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 591 n/a
Sep 23, 2014 vagelos p roy Officer Disposition (Non Open Market) 7,820 n/a
Sep 16, 2014 sanofi Beneficial Owner (10% or more) Buy 31,717 347.78 - 349.91
Sep 15, 2014 sanofi Beneficial Owner (10% or more) Buy 80,824 340.88 - 346.70
Sep 12, 2014 sanofi Beneficial Owner (10% or more) Buy 59,808 345.07 - 347.92
Sep 10, 2014 vagelos p roy Officer Automatic Sell 10,326 350.07
Sep 8, 2014 vagelos p roy Officer Automatic Sell 2 351.00
Sep 5, 2014 vagelos p roy Officer Disposition (Non Open Market) 4 n/a
Aug 28, 2014 yancopoulos george Officer Disposition (Non Open Market) 294 n/a
Aug 28, 2014 yancopoulos george Officer Acquisition (Non Open Market) 294 n/a
Aug 27, 2014 goldstein joseph l Director Sell 2,000 350.31
Aug 27, 2014 mccorkle douglas s Officer Option Execute 1,681 21.25 - 30.63
Aug 27, 2014 tessier-lavigne marc Director Sell 3,000 352.20
Aug 27, 2014 tessier-lavigne marc Director Option Execute 3,000 50.91
Showing 101-120 of 951 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)